More recently, JP Morgan Private Capital, a venture capital and growth equity investment team under JP Morgan Asset Management, raised over $500 million for a life sciences fund targeting private biotech companies with a keen focus on the weight-loss drug space.
C.RichardsJ
Clean ingredients, no fillers finally something that delivers on the GLP-1 support promises
Tirzepatide, the first dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) RA approved for both conditions, has paved the way for next-generation incretin-based therapies
This dose level also showed the greatest total fat mass reduction in the body composition substudy, with participants losing an average of 21.6kg of pure fat mass compared to placebo
Pre-packaged fruit juices, soups, sports drinks, coffee, frozen diet meals, tea, granola and energy bars are among the foods that will see the least reduction in consumption, the firm said